BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 12717448)

  • 21. In vitro and in vivo assays of monoubiquitination of receptor tyrosine kinases.
    Katz M; Mosesson Y; Yarden Y
    Methods Mol Biol; 2006; 327():115-29. PubMed ID: 16780216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteasomal degradation of the nuclear targeting growth factor midkine.
    Suzuki N; Shibata Y; Urano T; Murohara T; Muramatsu T; Kadomatsu K
    J Biol Chem; 2004 Apr; 279(17):17785-91. PubMed ID: 14970216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ubiquitination of a yeast plasma membrane receptor signals its ligand-stimulated endocytosis.
    Hicke L; Riezman H
    Cell; 1996 Jan; 84(2):277-87. PubMed ID: 8565073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular mechanism of insulin-induced degradation of insulin receptor substrate 1.
    Zhande R; Mitchell JJ; Wu J; Sun XJ
    Mol Cell Biol; 2002 Feb; 22(4):1016-26. PubMed ID: 11809794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Ligand-induced polyubiquitination of receptor tyrosine kinases].
    Mori S
    Tanpakushitsu Kakusan Koso; 1997 Oct; 42(14 Suppl):2284-90. PubMed ID: 9366209
    [No Abstract]   [Full Text] [Related]  

  • 26. Dimerization, ubiquitylation and endocytosis go together in growth hormone receptor function.
    Strous GJ; Gent J
    FEBS Lett; 2002 Oct; 529(1):102-9. PubMed ID: 12354620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta(2)-adrenergic receptor down-regulation. Evidence for a pathway that does not require endocytosis.
    Jockers R; Angers S; Da Silva A; Benaroch P; Strosberg AD; Bouvier M; Marullo S
    J Biol Chem; 1999 Oct; 274(41):28900-8. PubMed ID: 10506134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endocytosis of receptor tyrosine kinases.
    Goh LK; Sorkin A
    Cold Spring Harb Perspect Biol; 2013 May; 5(5):a017459. PubMed ID: 23637288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. E3 ubiquitin ligases as regulators of membrane protein trafficking and degradation.
    d'Azzo A; Bongiovanni A; Nastasi T
    Traffic; 2005 Jun; 6(6):429-41. PubMed ID: 15882441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Localization to the proteasome is sufficient for degradation.
    Janse DM; Crosas B; Finley D; Church GM
    J Biol Chem; 2004 May; 279(20):21415-20. PubMed ID: 15039430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling.
    Berndt JD; Aoyagi A; Yang P; Anastas JN; Tang L; Moon RT
    J Cell Biol; 2011 Sep; 194(5):737-50. PubMed ID: 21875946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conjugation to Nedd8 instigates ubiquitylation and down-regulation of activated receptor tyrosine kinases.
    Oved S; Mosesson Y; Zwang Y; Santonico E; Shtiegman K; Marmor MD; Kochupurakkal BS; Katz M; Lavi S; Cesareni G; Yarden Y
    J Biol Chem; 2006 Aug; 281(31):21640-21651. PubMed ID: 16735510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trafficking, ubiquitination, and down-regulation of the human platelet-activating factor receptor.
    Dupré DJ; Chen Z; Le Gouill C; Thériault C; Parent JL; Rola-Pleszczynski M; Stankova J
    J Biol Chem; 2003 Nov; 278(48):48228-35. PubMed ID: 14500726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Ankrd 13 family of UIM-bearing proteins regulates EGF receptor endocytosis from the plasma membrane.
    Tanno H; Yamaguchi T; Goto E; Ishido S; Komada M
    Mol Biol Cell; 2012 Apr; 23(7):1343-53. PubMed ID: 22298428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controlling receptor downregulation by ubiquitination and deubiquitination.
    Komada M
    Curr Drug Discov Technol; 2008 Mar; 5(1):78-84. PubMed ID: 18537571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vesicular trafficking of tyrosine kinase receptors and associated proteins in the regulation of signaling and vascular function.
    Mukherjee S; Tessema M; Wandinger-Ness A
    Circ Res; 2006 Mar; 98(6):743-56. PubMed ID: 16574915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 'ER degradation' of a mutant yeast plasma membrane protein by the ubiquitin-proteasome pathway.
    Galan JM; Cantegrit B; Garnier C; Namy O; Haguenauer-Tsapis R
    FASEB J; 1998 Mar; 12(3):315-23. PubMed ID: 9506475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteasome regulates the delivery of LDL receptor-related protein into the degradation pathway.
    Melman L; Geuze HJ; Li Y; McCormick LM; Van Kerkhof P; Strous GJ; Schwartz AL; Bu G
    Mol Biol Cell; 2002 Sep; 13(9):3325-35. PubMed ID: 12221136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A ubiquitin-interacting motif conserved in components of the proteasomal and lysosomal protein degradation systems.
    Hofmann K; Falquet L
    Trends Biochem Sci; 2001 Jun; 26(6):347-50. PubMed ID: 11406394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ligand-activated platelet-derived growth factor beta-receptor is degraded through proteasome-dependent proteolytic pathway.
    Mori S; Kanaki H; Tanaka K; Morisaki N; Saito Y
    Biochem Biophys Res Commun; 1995 Dec; 217(1):224-9. PubMed ID: 8526915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.